Song, Y., Lin, L., Liu, D., Zhu, M., Wang, P., Li, K., . . . Ye, Z. (2026). Integrative analysis and functional validation identified palmitoylated PHGDH as a therapeutic target for colon adenocarcinoma. Cellular Oncology (2211-3428), 49(2), 1. https://doi.org/10.1007/s13402-026-01207-4
Chicago Style (17th ed.) CitationSong, Yixian, Lingling Lin, Dejian Liu, Mengqing Zhu, Pei Wang, Ke Li, Aimin Li, Kequan Chen, and Zhanhui Ye. "Integrative Analysis and Functional Validation Identified Palmitoylated PHGDH as a Therapeutic Target for Colon Adenocarcinoma." Cellular Oncology (2211-3428) 49, no. 2 (2026): 1. https://doi.org/10.1007/s13402-026-01207-4.
MLA (9th ed.) CitationSong, Yixian, et al. "Integrative Analysis and Functional Validation Identified Palmitoylated PHGDH as a Therapeutic Target for Colon Adenocarcinoma." Cellular Oncology (2211-3428), vol. 49, no. 2, 2026, p. 1, https://doi.org/10.1007/s13402-026-01207-4.